Huaren Pharmaceutical Co., Ltd. (300110.SZ) SHZ

3.21

+0(+0.00%)

Updated at September 26 03:04PM

Currency In CNY

Huaren Pharmaceutical Co., Ltd.

Address

High-tech Industrial Park

Qingdao, 266101

China

Phone

86 532 8870 1000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2681

First IPO Date

August 25, 2010

Key Executives

NameTitlePayYear Born
Mr. Liang HongExecutive Chief Executive Officer01971
Mr. Jian LinPresident01982
Ms. Xiangyuan MengVice President & Board Secretary01988
Ms. Liping HanVice President & Chief Financial Officer01985

Description

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. It also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and carbohydrate metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine solution protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, the company offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. Huaren Pharmaceutical Co., Ltd. was founded in 1998 and is based in Qingdao, China.